RegeneRx Biopharma receives patent in Korea

Drug Discovery |  News | 0 Comment | 23 Jan, 2020

US based RegeneRx Biopharmaceuticals, a clinical-stage drug development company focused on tissue protection, repai...Read more

Hitachi Chemical inks pact with Ori Biotech

Drug Discovery |  News | 0 Comment | 23 Jan, 2020

Hitachi Chemical Advanced Therapeutics Solutions, LLC,  a US subsidiary of Japanese firm Hitachi Chemical Co., Ltd....Read more

PhoreMost, Otsuka collaborate for multi drug discovery projects

Drug Discovery |  News | 0 Comment | 22 Jan, 2020

PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease target...Read more

ViiV Healthcare wins Japanese approval for Dovato to treat HIV-1

Drug Discovery |  News | 0 Comment | 20 Jan, 2020

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as share...Read more

InterVenn Biosciences advances glycoproteomics for complex disease therapies

Drug Discovery |  News | 0 Comment | 17 Jan, 2020

US based InterVenn Biosciences has announced multiple achievements in its development of AI-enabled glycoproteomics, as ...Read more

Charles River inks scientific collaboration with Takeda

Drug Discovery |  News | 0 Comment | 16 Jan, 2020

US based company Charles River has announced a multi-year drug discovery collaboration with Japanese firm Takeda Pharmac...Read more

Hitachi starts commercial manufacturing of Zynteglo

Drug Discovery |  News | 0 Comment | 15 Jan, 2020

apceth Biopharma GmbH, a subsidiary of Japan headquartered Hitachi Chemical Co., Ltd. and a leading company for the manu...Read more

FDA approves sNDA for Astellas’s antifungal drug

Drug Discovery |  News | 0 Comment | 13 Jan, 2020

Japan based Astellas Pharma Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved its supplem...Read more

China approves AstraZeneca’s Lokelma to treat hyperkalaemia

Drug Discovery |  News | 0 Comment | 07 Jan, 2020

AstraZeneca’s Lokelma (sodium zirconium cyclosilicate) has been approved in China for the treatment of a...Read more

China grants priority review to Luye Pharma's schizophrenia drug

Drug Discovery |  News | 0 Comment | 02 Jan, 2020

Luye Pharma Group has announced that the New Drug Application (NDA) for Risperidone Extended-Release Microspheres for In...Read more

AstraZeneca’s triple-combination therapy gets approval in China for COPD

Drug Discovery |  News | 0 Comment | 01 Jan, 2020

AstraZeneca has announced that budesonide/glycopyrronium/formoterol fumarate has been approved in China for the maintena...Read more

Luye Pharma seeks USFDA approval for antidepressant drug

Drug Discovery |  News | 0 Comment | 30 Dec, 2019

China based Luye Pharma Group has announced submission of a new drug application (NDA) to the U.S. Food and Drug Adminis...Read more

USFDA approves Daiichi Sankyo and AstraZeneca’s breast cancer drug

Drug Discovery |  News | 0 Comment | 26 Dec, 2019

Daiichi Sankyo and AstraZeneca have announced that the U.S. Food and Drug Administration (FDA) has approved ENHERTU®...Read more

Allergan gets FDA nod for acute migraine treatment

Drug Discovery |  News | 0 Comment | 24 Dec, 2019

The U.S. Food and Drug Administration has approved Ubrelvy (ubrogepant) tablets for the acute (immediate) treatment of m...Read more

Eisai gets USFDA nod for insomnia drug

Drug Discovery |  News | 0 Comment | 24 Dec, 2019

Eisai has announced that the U.S. Food and Drug Administration (FDA) approved DAYVIGO™ (lemborexant) 5 mg and...Read more

BeiGene cancer drug misses mark in Phase III study

Drug Discovery |  News | 0 Comment | 20 Dec, 2019

China based BeiGene,  a commercial-stage biopharmaceutical company focused on developing and commercializing innova...Read more

Takeda, Turnstone Biologics to develop novel viral immunotherapies

Drug Discovery |  News | 0 Comment | 20 Dec, 2019

US based Turnstone Biologics, a biotechnology company pioneering the development of engineered viral immunotherapies,&nb...Read more

European Commission approves Roche’s breast cancer drug

Drug Discovery |  News | 0 Comment | 19 Dec, 2019

Roche has announced that the European Commission has approved Kadcyla® (trastuzumab emtansine) for the adjuvant (aft...Read more